Scholarlink

<p><i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) represents a critical global health challenge due to its escalating antibiotic resistance and its formidable ability to form protective biofilms, necessitating the urgent development of novel therapeutic strategies. This research explores the potential of allicin, a natural antibacterial compound, encapsulated within alginate-casein (ACAN) nanoparticles as a promising approach to combat multidrug-resistant (MDR) <i>P. aeruginosa</i> proliferation and biofilm formation. The ACAN nanoparticles were comprehensively characterized for their morphological traits using FESEM, DLS, and FTIR, confirming successful allicin encapsulation and enhanced stability. Notably, the ACAN formulation demonstrated significantly improved antibacterial efficacy and a profound ability to inhibit biofilm growth. Specifically, ACAN nanoparticles achieved up to 77% inhibition of <i>P. aeruginosa</i> biofilm growth, a statistically significant improvement compared to free allicin (e.g., ~ 28% inhibition). Furthermore, the study investigated the impact of ACAN on key biofilm-related genes, revealing a marked downregulation of <i>pslG</i> (involved in exopolysaccharide production) and <i>lasI</i> (critical for quorum sensing and biofilm maturation). These findings collectively highlight that encapsulating allicin within alginate-casein nanoparticles not only enhances its stability and delivery but also significantly boosts its efficacy against the persistent biofilm-forming capabilities of MDR <i>P. aeruginosa</i>. This novel ACAN platform thus presents a compelling and promising therapeutic strategy for addressing challenging bacterial infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Antibacterial activity of alginate-casein nanocapsules containing allicin against multidrug-resistant Pseudomonas aeruginosa

  • 期刊论文

  • 发表日期：

    2025年7月28日

查看全文
  • Saeed Homaei,
  • Hedieh Ghourchian,
  • Tohid Piri-Gharaghie

摘要

Pseudomonas aeruginosa (P. aeruginosa) represents a critical global health challenge due to its escalating antibiotic resistance and its formidable ability to form protective biofilms, necessitating the urgent development of novel therapeutic strategies. This research explores the potential of allicin, a natural antibacterial compound, encapsulated within alginate-casein (ACAN) nanoparticles as a promising approach to combat multidrug-resistant (MDR) P. aeruginosa proliferation and biofilm formation. The ACAN nanoparticles were comprehensively characterized for their morphological traits using FESEM, DLS, and FTIR, confirming successful allicin encapsulation and enhanced stability. Notably, the ACAN formulation demonstrated significantly improved antibacterial efficacy and a profound ability to inhibit biofilm growth. Specifically, ACAN nanoparticles achieved up to 77% inhibition of P. aeruginosa biofilm growth, a statistically significant improvement compared to free allicin (e.g., ~ 28% inhibition). Furthermore, the study investigated the impact of ACAN on key biofilm-related genes, revealing a marked downregulation of pslG (involved in exopolysaccharide production) and lasI (critical for quorum sensing and biofilm maturation). These findings collectively highlight that encapsulating allicin within alginate-casein nanoparticles not only enhances its stability and delivery but also significantly boosts its efficacy against the persistent biofilm-forming capabilities of MDR P. aeruginosa. This novel ACAN platform thus presents a compelling and promising therapeutic strategy for addressing challenging bacterial infections.